Endeavor CEO Linda Rottenberg features Biorce alongside SpaceX, ElevenLabs and Cashea in this Inc. article.

Clinical Trial Feasibility is often underestimated, taking nearly two months. Learn how our Senior Director rethinks the process.

Philipp Liehe and Marcelo Jiménez, have successfully defended their Master's Theses and now joined the Biorce Engineering team.

Biorce brings Aika 2.0 to BIO 2026 with live demo rides in San Diego

Oncology protocols amend more often and differently, with higher amendment rates, greater complexity, and sharper consequences for trial completion.

Protocol amendments cost hundreds of thousands of dollars and add months to trials. Discover the hidden financial and operational impact of protocol changes.

Aika's AI-generated protocol anticipated 54.8% of eligibility criteria later added through protocol amendments. Reduce clinical trial delays and costs.

Austin-based outlet Tech Scoop Austin featured Biorce’s R&D hub as part of the city’s growing tech scene.

The real risk in sensitive clinical data security goes beyond data location. It’s how AI platforms are built, monitored, and secured.

LinkedIn influencer Joanna Sadowska explores how AI is transforming drug discovery and development, empowering scientists and patients with better tools.